Arseus (company)
Encyclopedia
Arseus N.V. is a Belgian
healthcare company founded in 2006 as a spin-off from Omega Pharma
. It is active in medical IT solutions, dental products, medical and surgical products and magistral preparations for pharmacies.
At the occasion of the annual shareholders meeting of June 6th 2006 of Omega Pharma was announced that Arseus will be the new company name under which the Professional Health division of Omega Pharma will operate. The legal structure of the entities in this division has been largely prepared in the mean time, so that the project to make Arseus an autonomous company is on schedule. In the framework of this project, it is expected that Arseus, as an autonomous company, will become stock-listed by 2008.
Arseus covers the activities of Omega Pharma that are targeted towards professional users in the pharmaceutical and medical environment, like pharmacists, medical practitioners in various medical disciplines (dentists, ophthalmologists, …), opticians, nurses, professional staff in hospitals, caring homes and nursing homes. These activities have until now been organised according to the corresponding business units of Omega Pharma; i.e.: the activities of the Fagron Group (raw materials and equipment for the pharmacy), OmegaSoft http://www.omegasoft.be (IT solutions for the medical environment), Omega Dental (products and services for dental surgery and dental care), Omega Medical (products and services for hospitals, healthcare institutions, home care and nursing homes).
Arseus has approximately 1,300 employees, spread throughout Belgium, the Netherlands, France, Germany, Spain and Switzerland. Arseus plans to expand its activities towards all other European markets.
In 2005, the Professional Health Division, now Arseus, generated an annual turnover of €284 million, which is 30% of the consolidated turnover of Omega Pharma.
Belgium
Belgium , officially the Kingdom of Belgium, is a federal state in Western Europe. It is a founding member of the European Union and hosts the EU's headquarters, and those of several other major international organisations such as NATO.Belgium is also a member of, or affiliated to, many...
healthcare company founded in 2006 as a spin-off from Omega Pharma
Omega Pharma
Omega Pharma is a Belgian Pharmaceutical company, founded in 1987 by Marc Coucke and Yvan Vindevogel, both former Pharmacy students at the Ghent University.The company is quoted at Euronext Brussels and makes part of the BEL20 index.-Arseus:...
. It is active in medical IT solutions, dental products, medical and surgical products and magistral preparations for pharmacies.
At the occasion of the annual shareholders meeting of June 6th 2006 of Omega Pharma was announced that Arseus will be the new company name under which the Professional Health division of Omega Pharma will operate. The legal structure of the entities in this division has been largely prepared in the mean time, so that the project to make Arseus an autonomous company is on schedule. In the framework of this project, it is expected that Arseus, as an autonomous company, will become stock-listed by 2008.
Arseus covers the activities of Omega Pharma that are targeted towards professional users in the pharmaceutical and medical environment, like pharmacists, medical practitioners in various medical disciplines (dentists, ophthalmologists, …), opticians, nurses, professional staff in hospitals, caring homes and nursing homes. These activities have until now been organised according to the corresponding business units of Omega Pharma; i.e.: the activities of the Fagron Group (raw materials and equipment for the pharmacy), OmegaSoft http://www.omegasoft.be (IT solutions for the medical environment), Omega Dental (products and services for dental surgery and dental care), Omega Medical (products and services for hospitals, healthcare institutions, home care and nursing homes).
Arseus has approximately 1,300 employees, spread throughout Belgium, the Netherlands, France, Germany, Spain and Switzerland. Arseus plans to expand its activities towards all other European markets.
In 2005, the Professional Health Division, now Arseus, generated an annual turnover of €284 million, which is 30% of the consolidated turnover of Omega Pharma.